# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-25-009739
Filing Date
2025-07-29
Accepted
2025-07-29 16:15:18
Documents
44
Period of Report
2025-07-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | acrs-20250729x8k.htm iXBRL | 8-K | 41439
2 | EX-99.1 | acrs-20250729xex99d1.htm | EX-99.1 | 42636
3 | EX-99.2 | acrs-20250729xex99d2.htm | EX-99.2 | 34898
4 | GRAPHIC | acrs-20250729xex99d1g001.jpg | GRAPHIC | 117419
5 | GRAPHIC | acrs-20250729xex99d1g002.jpg | GRAPHIC | 302840
6 | GRAPHIC | acrs-20250729xex99d1g003.jpg | GRAPHIC | 100277
7 | GRAPHIC | acrs-20250729xex99d1g004.jpg | GRAPHIC | 153122
8 | GRAPHIC | acrs-20250729xex99d1g005.jpg | GRAPHIC | 118768
9 | GRAPHIC | acrs-20250729xex99d1g006.jpg | GRAPHIC | 119595
10 | GRAPHIC | acrs-20250729xex99d1g007.jpg | GRAPHIC | 104097
11 | GRAPHIC | acrs-20250729xex99d1g008.jpg | GRAPHIC | 113113
12 | GRAPHIC | acrs-20250729xex99d1g009.jpg | GRAPHIC | 101534
13 | GRAPHIC | acrs-20250729xex99d1g010.jpg | GRAPHIC | 81909
14 | GRAPHIC | acrs-20250729xex99d1g011.jpg | GRAPHIC | 125394
15 | GRAPHIC | acrs-20250729xex99d1g012.jpg | GRAPHIC | 118161
16 | GRAPHIC | acrs-20250729xex99d1g013.jpg | GRAPHIC | 124964
17 | GRAPHIC | acrs-20250729xex99d1g014.jpg | GRAPHIC | 119493
18 | GRAPHIC | acrs-20250729xex99d1g015.jpg | GRAPHIC | 156671
19 | GRAPHIC | acrs-20250729xex99d1g016.jpg | GRAPHIC | 136458
20 | GRAPHIC | acrs-20250729xex99d1g017.jpg | GRAPHIC | 101745
21 | GRAPHIC | acrs-20250729xex99d1g018.jpg | GRAPHIC | 107572
22 | GRAPHIC | acrs-20250729xex99d1g019.jpg | GRAPHIC | 138655
23 | GRAPHIC | acrs-20250729xex99d1g020.jpg | GRAPHIC | 118703
24 | GRAPHIC | acrs-20250729xex99d1g021.jpg | GRAPHIC | 111257
25 | GRAPHIC | acrs-20250729xex99d1g022.jpg | GRAPHIC | 136022
26 | GRAPHIC | acrs-20250729xex99d1g023.jpg | GRAPHIC | 119971
27 | GRAPHIC | acrs-20250729xex99d1g024.jpg | GRAPHIC | 113486
28 | GRAPHIC | acrs-20250729xex99d1g025.jpg | GRAPHIC | 174978
29 | GRAPHIC | acrs-20250729xex99d1g026.jpg | GRAPHIC | 71355
30 | GRAPHIC | acrs-20250729xex99d1g027.jpg | GRAPHIC | 119625
31 | GRAPHIC | acrs-20250729xex99d1g028.jpg | GRAPHIC | 117419
32 | GRAPHIC | acrs-20250729xex99d2001.jpg | GRAPHIC | 8678
33 | GRAPHIC | acrs-20250729xex99d2002.jpg | GRAPHIC | 12836
| Complete submission text file | 0001558370-25-009739.txt |  | 5078940

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
34 | EX-101.SCH | acrs-20250729.xsd | EX-101.SCH | 3462
35 | EX-101.LAB | acrs-20250729_lab.xml | EX-101.LAB | 15916
36 | EX-101.PRE | acrs-20250729_pre.xml | EX-101.PRE | 10223
46 | EXTRACTED XBRL INSTANCE DOCUMENT | acrs-20250729x8k_htm.xml | XML | 4840

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 251162054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)